Table 3 Cox proportional hazard models (adjusted for age and sex)
From: Scores to predict steatotic liver disease – correlates and outcomes in older adults
MASLD scores | All-cause mortality | MACE | Atrial fibrillation | Persistent physical disability |
|---|---|---|---|---|
FLI (HR [95% CI]) <30 (No MASLD) | ||||
30–60 | 0.92 (0.79–1.06) | 1.19 (0.97–1.46) | 1.16 (0.91–1.50) | 1.14 (0.90–1.44) |
≥60 (MASLD) | 1.10 (0.96–1.27) | 1.36 (1.11–1.66) | 1.48 (1.16–1.88) | 2.12 (1.72–2.62) |
LAP (HR [95% CI]) | ||||
No MASLD MASLD | 1.06 (0.94–1.19) | 1.41 (1.20–1.66) | 1.12 (0.93–1.36) | 1.60 (1.34–1.91) |
HSI (HR [95% CI]) <30 (No MASLD) | ||||
30–36 | 0.66 (0.55–0.78) | 0.83 (0.63–1.08) | 0.94 (0.67–1.32) | 0.71 (0.53–0.96) |
≥36 (MASLD) | 0.72 (0.60–0.86) | 1.05 (0.80–1.37) | 1.24 (0.88–1.73) | 1.32 (0.99–1.76) |
ZJU (HR [95% CI]) <32 (No MASLD) | ||||
32–38 | 0.63 (0.53–0.76) | 0.96 (0.71–1.30) | 0.83 (0.59–1.18) | 0.65 (0.47–0.90) |
≥38 (MASLD) | 0.71 (0.59–0.85) | 1.18 (0.87–1.60) | 1.08 (0.76–1.53) | 1.26 (0.92–1.71) |
FSI (HR [95% CI]) | ||||
No MASLD MASLD | 0.99 (0.88–1.11) | 1.24 (1.06–1.46) | 1.25 (1.03–1.51) | 1.74 (1.47–2.07) |
DSI (HR [95% CI]) < −1.4 (no MASLD) | ||||
−1.4–0 | 0.93 (0.81–1.06) | 1.06 (0.88–1.27) | 1.14 (0.92–1.41) | 1.28 (1.05–1.57) |
≥0 (MASLD) | 1.04 (0.89–1.21) | 1.21 (0.98–1.49) | 1.13 (0.87–1.46) | 1.90 (1.53–2.37) |
VAI (HR [95% CI]) No MASLD | ||||
MASLD | 1.08 (0.87–1.22) | 1.49 (1.27–1.75) | 0.94 (0.78–1.14) | 1.41 (1.18–1.67) |
